Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.
about
Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage PolarizationMesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsInternational Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic propertiesOlf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus.The generation and maintenance of serum alloantibody.Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.Secretion of immunoregulatory cytokines by mesenchymal stem cells.beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.New concepts on the immune modulation mediated by mesenchymal stem cells.Bone marrow stromal cells as immunomodulators. A primer for dermatologists.Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model.Mesenchymal stem cells facilitate mixed hematopoietic chimerism induction and prevent onset of diabetes in nonobese diabetic miceMesenchymal stem cells do not prevent antibody responses against human α-L-iduronidase when used to treat mucopolysaccharidosis type I.Regulation of Immunity via Multipotent Mesenchymal Stromal Cells.Immunomodulatory effect of mesenchymal stem cells on B cells.How mesenchymal stem cells interact with tissue immune responses.Inducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarization.CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFαMesenchymal stromal cells in transplantation rejection and tolerance.Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patientsCCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms.Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparationsMesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in B lymphocytes.Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies.Allogeneic mesenchymal stem cells: agents of immune modulation.Mesenchymal stromal cells for cardiovascular disease.Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells.New insights on translational development of mesenchymal stromal cells for suppressor therapy.Mesenchymal stromal cells: a key player in 'innate tolerance'?Plasma cells in immunopathology: concepts and therapeutic strategies.Are stem cells a potential therapeutic tool in coeliac disease?Mesenchymal stem cells: a friend or foe in immune-mediated diseases.Mesenchymal stem cell-based therapy for nonhealing wounds: today and tomorrow.The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.Interleukin-36 receptor mediates the crosstalk between plasma cells and synovial fibroblasts.
P2860
Q26800098-6920BDE3-3E34-4E9F-B5E5-C6458C25A80BQ28085080-11C13255-60B7-4BAA-A6B9-E47BCBFCF313Q30488740-47916D35-1803-4CAB-9FEE-02B2F7E7F7EAQ33659353-608E5D98-5015-4B7F-8EF8-D3993B0EEC79Q33685495-F155CB96-753B-4942-BF64-0FF920D4F234Q33861809-3C4F50E7-2122-4D00-9BB1-8369BD981272Q33923396-C357A0BF-983E-4EA8-BAF2-FAF99E6F3860Q34106158-4E6A839A-4045-45F8-A956-790B9F469A5DQ34238869-B9A90AEF-4508-4464-9526-3A2E59AAD665Q34259098-F8809B03-6E45-4048-AF9E-DA06D179F924Q34356438-55EEF916-3D26-4BC6-80F7-DA3780686BCDQ34513159-1E5A75AB-7E86-4A4D-B7DA-2CB161807621Q34961598-8B5856A1-F6E6-4807-A587-B0E10201825FQ35080099-4666FD5A-0493-41A3-A394-8D98493A9CB6Q35112634-ED124413-0C0D-442D-9B79-34E007B0E0A8Q35124024-AC6F90CB-FAF8-40A3-849F-20086A7E10ADQ36025982-9A19D39C-AA0A-4A75-A8A6-E6FCD03BF14FQ36105639-1EE391C2-48CC-484A-A9C5-D31DF7420F4FQ36141205-FCB64F3D-1024-415D-A2BB-4C1A2C1C17DBQ36220700-5C07DAD0-1011-4065-86F9-93B8DBF67EB2Q36456715-97D8FABC-4E43-4CD3-84B8-B70545942DBFQ36786630-423D9BFD-3D62-4D2E-8E7C-B897F58FA184Q37077035-BC9D49FB-6D1B-4669-B443-8661B401A782Q37089931-79793AF6-698A-44DE-A5C4-A561D7684930Q37602101-A032D058-74FB-4562-A25B-8C13585E6215Q37667547-171F921A-51F7-46EF-B1FF-6D637AA39D1BQ37726116-09540B1D-0454-4282-ABAA-B9965429F19DQ37742101-8DB99896-013F-4013-8796-BD5BFE9D02F9Q37858927-54FF3AA2-7A1D-4B95-B4EC-206682FE715CQ37895928-64A09EA2-F823-4265-9D52-20A4F3B50786Q37924625-D8B2FD7B-92BD-43DA-9FED-9B55AF9DECB8Q37989396-FEE6FAD7-6D42-4890-AEC9-F2EF09540165Q38026931-F1A2E944-08A5-4B1F-AD30-42F1B8F4FDBDQ38205130-2AB84E40-F6EC-4F65-A3FB-E8FF789BEF82Q38289416-0B4612DA-4CF0-42DD-BE04-316EB3E53E28Q38319943-1B4749B4-4DC4-41F6-9B69-5C6B1487DE1FQ38422834-7B6BE99B-C33B-49C6-9B75-178C0F5702D2Q38442767-DBBEDC06-3696-477C-BE0C-297175B48C6DQ38569328-5B40ED64-78CC-44B6-A36B-0C9042B176BDQ38600649-7ACAC32D-E6B2-47F8-912A-E0B804E0D18A
P2860
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.
@en
Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.
@nl
type
label
Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.
@en
Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.
@nl
prefLabel
Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.
@en
Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.
@nl
P2093
P1433
P1476
Mesenchymal stromal cell-deriv ...... activation and PAX5 induction.
@en
P2093
Borhane Annabi
Elena Birman
Jacques Galipeau
Jeremy Hsieh
Karen Doody
Kathy Forner
Marie-Noelle Boivin
Mengyang Li
Michel Tremblay
Moutih Rafei
P304
P356
10.1182/BLOOD-2008-07-166892
P407
P577
2008-09-23T00:00:00Z